Paul Dolan

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

Read more

• Canada
• Denmark
• England
• France
• Germany
• HTA
• Oncology
• Roche
• Scotland
• Sweden
• Health Technology Assessment…
• Precision Medicine

Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies

Read more

• Cancer Research UK
• Innovation
• NHS
• Oncology
• Pricing and Reimbursement
• UK
• Healthcare Systems
• Real World Evidence (RWE)
• Value-Based Pricing

Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations

Read more

• Economic Evaluation
• Healthcare Delivery
• NHS
• Novartis
• UK
• Chronic Diseases
• Healthcare Systems

After the Transplant: Potential Benefits for the NHS and UK Kidney Transplant Patients

Read more

• Determining Value
• England
• Epidemiology and Public Health
• External Publications
• NHS
• Pfizer
• Healthcare Systems
• Vaccines

The Value of Vaccines in Maintaining Health System Capacity in England

Read more